Updated:
IZI Medical Products
IZI Medical Products is a medical device manufacturer and distributor founded in 1991, based in Owings Mills, Maryland, and owned by Halma plc.
IZI Medical Products
IZI Medical Products was founded in 1991 by a neuroradiologist and radiation oncologist who sought to develop devices that increase procedural accuracy and reduce procedure time. The company, headquartered in Owings Mills, Maryland, began with products in image-guided surgery and radiation therapy, and has since expanded into interventional radiology, oncology, and neuro-spine care. IZI is part of Halma plc, a global group of life-saving technology companies headquartered in the United Kingdom (per Halma plc, 2025). IZI manufactures and distributes medical consumables for interventional procedures, with confirmed product lines including the Quick-Core Auto Biopsy Needle for soft tissue biopsy, the Blazer-C Vertebral Augmentation System, and the Vertefix MV bone cement infused with Insite Tracking Beads for vertebroplasty and kyphoplasty. The company's portfolio also covers breast localization products and other diagnostic and therapeutic interventional solutions. IZI sells to more than 2,000 domestic customers and distributes in 25 countries across North America, Europe, and other international markets (per the firm's website, 2025). The company does not disclose its AUM, revenue, or number of professionals. Halma plc, its parent, is a publicly traded company with a market capitalization exceeding £10 billion (as of early 2025). IZI does not appear to operate additional offices beyond its Owings Mills headquarters. The firm does not maintain a separate philanthropic foundation disclosed in its public materials. A key structural differentiator is IZI's ownership by Halma plc, a diversified industrial group that applies a growth-through-acquisition model. Halma owns over 40 companies globally, each operating autonomously. IZI benefits from Halma's capital and operational resources while retaining a focused, physician-driven product development strategy. This model contrasts with private-equity-backed medical device firms, which may face shorter investment horizons.
General information
Firm type
other
Year founded
1991
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Owings Mills
Corporate office
5 Easter Court, Suite J, Owings Mills, MD 21117, United States
Sector focus
Frequently asked questions
Who founded IZI Medical Products and when?
IZI Medical Products was founded in 1991 by a neuroradiologist and radiation oncologist who wanted to improve procedural accuracy and reduce time. The company remains focused on physician-inspired innovation in interventional radiology and spine care (per the firm's website, 2025).
Is IZI Medical Products a family office or an operating company?
IZI Medical Products is an operating medical device company, not a family office. It manufactures and distributes consumable devices used in interventional radiology, oncology, and spine procedures. The company is owned by Halma plc, a publicly traded UK-based industrial group (per Halma plc, 2025).
What investment stages or asset classes does IZI Medical Products represent?
IZI Medical Products does not invest capital externally; it is a portfolio company of Halma plc. Halma operates as a buy-and-hold acquirer of life-saving technology businesses, typically acquiring established companies with strong intellectual property and growth potential. IZI was likely an add-on acquisition within Halma's healthcare sector.
How does IZI Medical Products' ownership structure affect its strategy?
IZI operates as a standalone subsidiary of Halma plc, which provides long-term capital and strategic support without requiring a near-term exit. This ownership allows IZI to focus on product development and physician partnerships rather than quarterly earnings pressure. Halma's model emphasizes autonomous operations and decentralized decision-making (per Halma plc, 2025).
What geographic markets does IZI Medical Products serve?
IZI sells to more than 2,000 domestic customers in the United States and distributes products in 25 countries internationally. The company's headquarters is in Owings Mills, Maryland, and it does not disclose any additional office locations (per the firm's website, 2025).
What product areas does IZI Medical Products focus on?
IZI's portfolio includes soft tissue biopsy systems (Quick-Core Auto Biopsy Needle), breast localization products, vertebral augmentation systems (Blazer-C, Osteo-Site balloon), and bone cement for vertebroplasty and kyphoplasty (Vertefix MV). The company also has products for image-guided surgery and radiation therapy (per the firm's website, 2025).
Does IZI Medical Products disclose financial data?
IZI Medical Products does not publicly disclose its AUM, revenue, profitability, or number of employees. Financial data for the company is reported within Halma plc's consolidated filings, which are publicly available but not broken out for individual subsidiaries (Altss research).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: